Mandate

Vinge has advised Ingrid Capacity in new co-operation with Locus Energy, one of SEB Nordic Energy's portfolio companies

March 07, 2025 M&A

Vinge has advised Ingrid Capacity in connection with a new project together with Locus Energy, a leading Nordic energy infrastructure company owned by SEB Asset Management's SEB Nordic Energy fund, to develop Finland's largest and one of the Nordic region's largest battery storage systems.

The parties entered into a strategic partnership last year to increase the capacity of the national electricity grid and have now made a new joint investment in Finland's largest battery energy storage system, located in Nivala, Finland. The Nivala project is the second project of the partnership and a part of Ingrid Capacity's long-term vision to enable a resilient, cost-effective and sustainable electricity grid. The facility, which is planned to be commissioned in 2026, has a capacity of 70MW/140MWh and will be managed by Ingrid Capacity's proprietary and fully automated trading and optimisation platform, an advanced AI-powered software designed to make real-time decisions.

Vinge's team consisted primarily of Carl Sander, Vilhelm Rondahl, and Ellenor Eckerborn (M&A).

Please find more information here.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025